Spain - 33600000-6 Pharmaceuticals SEVILLE 0000911/2024 CONTR 2024 0001031923 PNAMSP 133/2024 SUPPLY OF SUCCESSIVE TRACT AND UNIT PRICE OF THE EXCLUSIVE MEDICATION IDECABTAGEN VICLEUCEL 400MILL CELLS/INYECTABLE IV
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 28 November 2024
- Opportunity publication date
- 28 October 2024
- Value of contract
- £5m-50m
- Your guide to exporting
Description
PNAMSP 133/2024 SUPPLY OF SUCCESSIVE PROCEDURE AND UNIT PRICE OF THE EXCLUSIVE MEDICATION IDECABTAGEN VICLEUCEL 400MILL CELLS/INYECTABLE IV-Pharmaceutical form: INJECTABLE IV, FOR THE HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO (HUVR), CENTER ATTACHED TO THE CENTRAL PROVINCIAL DE COMPRAS DE SEVILLA (CPC-SE), THROUGH A NEGOTIATED PROCEDURE WITHOUT ADVERTISING WITH THE COMPANY BRISTOL MYERS SQUIBB.. Tender amount (VAT excluded): 6.720.000,00€.
- Opportunity closing date
- 28 November 2024
- Value of contract
- £5m-50m
About the buyer
- Address
- Servicio Andaluz de Salud
Bid for tender
If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.
This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.
Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.
This opportunity has been translated from its original language. You should check if you need to apply in the original language.